CA2390670C - Methode de determination de la susceptibilite aux troubles bipolaires - Google Patents

Methode de determination de la susceptibilite aux troubles bipolaires Download PDF

Info

Publication number
CA2390670C
CA2390670C CA 2390670 CA2390670A CA2390670C CA 2390670 C CA2390670 C CA 2390670C CA 2390670 CA2390670 CA 2390670 CA 2390670 A CA2390670 A CA 2390670A CA 2390670 C CA2390670 C CA 2390670C
Authority
CA
Canada
Prior art keywords
patient
repeat
sample
allele
vntr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2390670
Other languages
English (en)
Other versions
CA2390670A1 (fr
Inventor
Pierandrea Muglia
James L. Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre for Addiction and Mental Health
Original Assignee
Centre for Addiction and Mental Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002350846A external-priority patent/CA2350846A1/fr
Application filed by Centre for Addiction and Mental Health filed Critical Centre for Addiction and Mental Health
Priority to CA 2390670 priority Critical patent/CA2390670C/fr
Publication of CA2390670A1 publication Critical patent/CA2390670A1/fr
Application granted granted Critical
Publication of CA2390670C publication Critical patent/CA2390670C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2390670 2001-06-15 2002-06-14 Methode de determination de la susceptibilite aux troubles bipolaires Expired - Fee Related CA2390670C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2390670 CA2390670C (fr) 2001-06-15 2002-06-14 Methode de determination de la susceptibilite aux troubles bipolaires

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,350,846 2001-06-15
CA002350846A CA2350846A1 (fr) 2001-06-15 2001-06-15 Methode de determination de la susceptibilite aux troubles bipolaires
CA 2390670 CA2390670C (fr) 2001-06-15 2002-06-14 Methode de determination de la susceptibilite aux troubles bipolaires

Publications (2)

Publication Number Publication Date
CA2390670A1 CA2390670A1 (fr) 2002-12-15
CA2390670C true CA2390670C (fr) 2014-08-05

Family

ID=25682622

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2390670 Expired - Fee Related CA2390670C (fr) 2001-06-15 2002-06-14 Methode de determination de la susceptibilite aux troubles bipolaires

Country Status (1)

Country Link
CA (1) CA2390670C (fr)

Also Published As

Publication number Publication date
CA2390670A1 (fr) 2002-12-15

Similar Documents

Publication Publication Date Title
Muglia et al. Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4
Kunugi et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder
Sander et al. Association analysis of sequence variants of the GABAAα6, β2, and γ2 gene cluster and alcohol dependence
US20090305900A1 (en) Genemap of the human genes associated with longevity
Souery et al. Linkage analysis of families with bipolar illness and chromosome 18 markers
US11214834B2 (en) Methods of detecting Charcot-Marie tooth disease type 2A
US7671187B2 (en) Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same
US20140186826A1 (en) Method of judging risk for onset of drug-induced granulocytopenia
EP2041304B1 (fr) Génotypes rgs2 associés aux symptômes extrapyramidaux induits par un médicament antipsychotique
Baron et al. Molecular genetics and human disease implications for modern psychiatric research and practice
US6998235B2 (en) Method of determining susceptibility to bipolar disorders
US20100003673A1 (en) Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders
CA2390670C (fr) Methode de determination de la susceptibilite aux troubles bipolaires
EP3545102B1 (fr) Détermination du génotype sous-jacent au phénotype s-s-u- du système mnss de groupe sanguin
CA2350846A1 (fr) Methode de determination de la susceptibilite aux troubles bipolaires
RU2800084C2 (ru) Способ получения молекулярных STR-маркеров Х-хромосомы для идентификации неизвестного индивида и определения биологического родства для работы с образцами малых количеств ДНК и набор олигонуклеотидов для его осуществления
Xu et al. A pooling genome-wide association study identifies susceptibility loci and signaling pathways of immune thrombocytopenia in Chinese Han population
US20050095590A1 (en) Brain expressed cap-2 gene and protein associated with bipolar disorder
US20060240461A1 (en) Methods for detecting nemaline myopathy
川西洋一 Investigation of genetic variants associated with schizophrenia
Lin Genetics of common psychiatric disorders: A Mendelian perspective based on genetic analyses of large pedigrees
van Hougenhouck-Tulleken Molecular Characterisation of the Extracellular Matrix Protein 1 Gene in Lipoid Proteinosis in South Africa
JP2006061056A (ja) 双極性障害検査方法及び検査薬

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170614